Epigenome-based cancer risk prediction: rationale, opportunities and challenges

Widschwendter, M; Jones, A; Evans, I; Reisel, D; Dillner, J; Sundström, K; Steyerberg, EW; ... FORECEE (4C) Consortium, .; + view all Widschwendter, M; Jones, A; Evans, I; Reisel, D; Dillner, J; Sundström, K; Steyerberg, EW; Vergouwe, Y; Wegwarth, O; Rebitschek, FG; Siebert, U; Sroczynski, G; de Beaufort, ID; Bolt, I; Cibula, D; Zikan, M; Bjørge, L; Colombo, N; Harbeck, N; Dudbridge, F; Tasse, A-M; Knoppers, BM; Joly, Y; Teschendorff, AE; Pashayan, N; FORECEE (4C) Consortium, .; - view fewer (2018) Epigenome-based cancer risk prediction: rationale, opportunities and challenges. Nature Reviews Clinical Oncology 10.1038/nrclinonc.2018.30 . (In press).

http://ift.tt/2CUkYYx